Mutations in SAMHD1 are associated with Aicardi–Goutières syndrome (AGS)—an autoimmune disorder characterized by a progressive inflammatory encephalopathy, spontaneous type I IFN production in the cerebrospinal fluid, and upregulated IFN-stimulated gene (ISG) expression [6]. Here, SAMHD1 is linked to Autoimmunity.